Announce Date | 04/23/2025 |
EPS Normalized Actual | $3.61 (Beat by $0.08) |
EPS GAAP Actual | $3.61 (Beat by $0.08) |
Revenue Actual | $1.0958B |
Revenue Surprise | Beat by $1095.8M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $6.78667 |
EPS GAAP Estimate | $6.78667 |
Revenue Estimate | $1.4969B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 32.15 | 11.62 | 31.56452 | 32.38974 | 0 |
Dec 2027 | 27.38 | 13.65 | 26.88139 | 27.58417 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.23 | 3.23 | 1.0958B | -0.06% | 1095.8M |
FQ4 2024 (Dec 2024) | 3.45 | 3.45 | 1.1229B | -0.41% | 1122.9M |
FQ3 2024 (Sep 2024) | 5.31 | 5.31 | 1.3336B | 5.53% | 1333.6M |
FQ2 2024 (Jun 2024) | 15.06 | 15.06 | 1.4506B | -5.19% | 1450.6M |
FQ1 2024 (Mar 2024) | 4.02 | 4.02 | 1.0965B | -7.51% | 1096.5M |
FQ4 2023 (Dec 2023) | 2.51 | 2.51 | 1.1275B | -29.01% | 1127.5M |
FQ3 2023 (Sep 2023) | 5.37 | 5.37 | 1.2598B | -42.41% | 1259.8M |
FQ2 2023 (Jun 2023) | 3.83 | 3.83 | 1.5259B | -21.04% | 1525.9M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
6.78667
Consensus Revenue Estimates
1.4969B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 6.4133 | -- | 6.25723 | 6.5618 | 1 |
FQ3 2027 (Sep 2027) | 7.9857 | -- | 7.79136 | 8.17061 | 1 |
FQ2 2027 (Jun 2027) | 8.6979 | -- | 8.48623 | 8.8993 | 1 |
FQ1 2027 (Mar 2027) | 4.3455 | -- | 4.23975 | 4.44612 | 1 |
FQ4 2026 (Oct 2026) | 3.4138 | -- | 3.32258 | 3.49384 | 1 |
FQ3 2026 (Jul 2026) | 3.6931 | -- | 3.59441 | 3.77968 | 1 |
FQ2 2026 (Jun 2026) | 7.0464 | -- | 6.97826 | 7.09452 | 1 |
FQ1 2026 (Mar 2026) | 3.7609 | 14.12 | 3.72453 | 3.78658 | 1 |
FQ4 2025 (Oct 2025) | 6.26667 | 44.95 | 6.09922 | 6.41359 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.45B | -- | 1.42B | 1.47B | 2 |
FQ3 2027 (Sep 2027) | 1.44B | -- | 1.41B | 1.46B | 2 |
FQ2 2027 (Jun 2027) | 1.43B | -- | 1.4B | 1.46B | 2 |
FQ1 2027 (Mar 2027) | 1.42B | -- | 1.39B | 1.45B | 2 |
FQ4 2026 (Oct 2026) | 1.17B | -- | 1.14B | 1.19B | 2 |
FQ3 2026 (Jul 2026) | 1.16B | -- | 1.14B | 1.18B | 2 |
FQ2 2026 (Jun 2026) | 3.95B | -- | 3.92B | 3.97B | 2 |
FQ1 2026 (Mar 2026) | 3.66B | 70.1 | 3.64B | 3.68B | 2 |
FQ4 2025 (Oct 2025) | 1.41B | 20.41 | 1.38B | 1.44B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.23 | 3.23 | 100% | |
FQ4 2024 (Dec 2024) | 3.45 | 3.45 | 100% | |
FQ3 2024 (Sep 2024) | 5.31 | 5.31 | 100% | |
FQ2 2024 (Jun 2024) | 15.06 | 15.06 | 100% | |
FQ1 2024 (Mar 2024) | 4.02 | 4.02 | 100% | |
FQ4 2023 (Dec 2023) | 2.51 | 2.51 | 100% | |
FQ3 2023 (Sep 2023) | 5.37 | 5.37 | 100% | |
FQ2 2023 (Jun 2023) | 3.83 | 3.83 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $1.1B | $1095.8M | 100% |
FQ4 2024 (Dec 2024) | $0B | $1.12B | $1122.9M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.33B | $1333.6M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.45B | $1450.6M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.1B | $1096.5M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.13B | $1127.5M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.26B | $1259.8M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.53B | $1525.9M | 100% |